PALLANTE, PIERLORENZO
 Distribuzione geografica
Continente #
AS - Asia 1.457
NA - Nord America 740
EU - Europa 384
SA - Sud America 305
AF - Africa 24
OC - Oceania 1
Totale 2.911
Nazione #
US - Stati Uniti d'America 712
SG - Singapore 673
CN - Cina 274
BR - Brasile 236
VN - Vietnam 184
HK - Hong Kong 173
NL - Olanda 98
FR - Francia 88
IT - Italia 86
KR - Corea 41
GB - Regno Unito 28
DE - Germania 27
AR - Argentina 26
JP - Giappone 23
BD - Bangladesh 16
CA - Canada 15
IN - India 15
EC - Ecuador 12
FI - Finlandia 10
ID - Indonesia 9
VE - Venezuela 8
ZA - Sudafrica 8
IL - Israele 7
MX - Messico 7
PL - Polonia 7
ES - Italia 6
PY - Paraguay 6
CO - Colombia 5
IQ - Iraq 5
MA - Marocco 5
SA - Arabia Saudita 5
UY - Uruguay 5
LT - Lituania 4
PK - Pakistan 4
SE - Svezia 4
UA - Ucraina 4
AL - Albania 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PH - Filippine 3
RU - Federazione Russa 3
TN - Tunisia 3
TR - Turchia 3
UZ - Uzbekistan 3
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
SV - El Salvador 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
IR - Iran 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 2.911
Città #
Singapore 382
Santa Clara 213
Hong Kong 173
San Jose 84
Lauterbourg 74
Beijing 69
Hefei 59
Ho Chi Minh City 57
Ashburn 54
Hanoi 47
Seoul 41
Los Angeles 32
Naples 21
Tokyo 19
São Paulo 18
Dallas 17
New York 15
Frankfurt am Main 12
Orem 11
Rome 11
Buffalo 10
Da Nang 10
Rio de Janeiro 9
Helsinki 8
Falkenstein 7
Portsmouth 7
Warsaw 7
Amsterdam 6
Bắc Giang 6
Chicago 6
Council Bluffs 6
Haiphong 6
Biên Hòa 5
Brooklyn 5
Düsseldorf 5
London 5
Manchester 5
Milan 5
Porto Alegre 5
Quito 5
Vũng Tàu 5
Atlanta 4
Brasília 4
Chennai 4
Curitiba 4
Feira de Santana 4
Genoa 4
Jakarta 4
Paris 4
Prineville 4
Quảng Ngãi 4
Quận Bình Thạnh 4
Stockholm 4
Tel Aviv 4
Toronto 4
Acalanes Ridge 3
Amman 3
Asunción 3
Belo Horizonte 3
Blumenau 3
Boston 3
Bắc Ninh 3
Campinas 3
Caxias do Sul 3
Charlotte 3
Dhaka 3
Durban 3
Formia 3
Houston 3
Madrid 3
Mauá 3
Minamishinagawa 3
Montevideo 3
Nairobi 3
Nam Định 3
Philadelphia 3
Phoenix 3
Piscataway 3
Plano 3
Quận Một 3
Recife 3
Seattle 3
Sesto Fiorentino 3
Tashkent 3
Tunis 3
Aracaju 2
Bento Gonçalves 2
Boardman 2
Buenos Aires 2
Bình Dương Province 2
Caetanópolis 2
Cape Town 2
Caracas 2
Casablanca 2
Chapecó 2
Chengdu 2
Concord 2
Delhi 2
Dublin 2
Faisalabad 2
Totale 1.718
Nome #
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. 67
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 63
Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer 63
A differential proteomic approach to identify proteins associated with thyroid cell transformation 61
Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis 60
Differential Expression of LncRNA in Bladder Cancer Development 57
CDH-16 Gene expression in thyroid cell differentiation and trasformation 56
Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas 55
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. Nanomedicine. 54
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. 54
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell 54
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. 52
The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors 51
Oncogenic Properties of the Antisense lncRNA COMET in BRAF- and RET-Driven Papillary Thyroid Carcinomas 50
The metallophosphoesterase-domain-containing protein 2 (MPPED2) gene acts as tumor suppressor in breast cancer 49
The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness 48
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 48
MPPED2 is downregulated in glioblastoma, and its restoration inhibits proliferation and increases the sensitivity to temozolomide of glioblastoma cells 47
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib 46
Tumour Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis. 46
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 46
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 45
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 45
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma 44
The control of tumor progression by circular RNAs: novel prognostic and therapeutic insights resulting from the analysis of the circAGO2/human antigen R complex 43
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle 42
BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report 41
The long non-coding RNA RP5-1024C24.1 and its associated-gene MPPED2 are down-regulated in human thyroid neoplasias and act as tumour suppressors 41
Deregulation of microRNA expression in thyroid neoplasias 40
The long non-coding RNA prader willi/angelman region RNA5 (PAR5) is downregulated in anaplastic thyroid carcinomas where it acts as a tumor suppressor by reducing EZH2 activity 40
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells. 40
Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. 39
CBX7 Modulates the Expression of Genes Critical for Cancer Progression 39
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin. 39
Noncoding RNAs in Thyroid-Follicular-Cell-Derived Carcinomas 38
High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ 36
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 36
The "next-generation" knowledge of papillary thyroid carcinoma 35
KRAS Mutant Allele-Specific Imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer. 34
Let-7a Down-Regulation Plays a Role in Thyroid Neoplasias of Follicular Histotype Affecting Cell Adhesion and Migration through Its Ability to Target the FXYD5 (Dysadherin) Gene 34
CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hurthle Cell Adenomas and Carcinomas). 34
High mobility group a proteins as tumor markers. 33
HMGA1 overexpression is associated with a particular subset of human breast carcinomas 33
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 33
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma. 33
HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models. 32
Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site 31
Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture 31
Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. 31
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs 30
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma 30
miR-191 Down-Regulation Plays a Role in Thyroid Follicular Tumors through CDK6 Targeting 30
Polycomb protein family member CBX7 plays a critical role in cancer progression 30
Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2 28
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy. 28
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 27
Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk 26
CBX7 and HMGA1b proteins act in opposite way on the regulation of the SPP1 gene expression 26
Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives 25
CBX7 is a tumor suppressor in mice and humans (vol 122, pg 612, 2012) 24
The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis 24
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status 24
A TSH-CREB1-microRNA Loop Is Required for Thyroid Cell Growth 23
Novel biomarkers of fibrosis in Crohn's disease. 23
The Interconnection Between UbcH10, p53, and EGFR in Lung Cancer Cells and Their Involvement in Treatment Response 22
CDH16/Ksp-cadherin is expressed in the developing thyroid gland and is strongly down-regulated in thyroid carcinomas. 22
Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2 22
UbcH10 expression in human lymphomas. (vol 54, pg 731, 2009) 22
Harmonization trial of FGFR1-3 testing strategies in cholangiocarcinoma patients: an Italian multicenter experience 21
EGFR mutation detection by microfluidic technology: a validation study 21
Performance of EGFR mutant-specific antibodies in different cytological preparations: A validation study 21
UbcH10 Expression on Thyroid Fine-Needle Aspirates 21
MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1 alpha 21
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma 20
High mobility group A1 expression correlates with the histological grade of human glial tumors 20
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer 20
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience 18
The "next-generation" knowledge of papillary thyroid carcinoma. 18
Tumor suppressor activity of CBX7 in lung carcinogenesis 18
Identification of a prognostic DNA repair gene signature in esophageal cancer 18
Tumor Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis 18
UbcH10 overexpression is less pronounced in older colorectal cancer patients 17
Role of PTPRJ genotype in papillary thyroid carcinoma risk 17
Thyrotropin Regulates Thyroid Cell Proliferation by Up-Regulating miR-23b and miR-29b that Target SMAD3 17
Transcriptional profile of Ki-Ras-induced transformation of thyroid cells 16
HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias 15
Totale 2.992
Categoria #
all - tutte 10.539
article - articoli 10.386
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202434 0 0 0 0 0 0 0 0 2 0 26 6
2024/20251.212 15 6 107 48 189 60 26 87 49 115 275 235
2025/20261.746 61 109 148 259 380 76 293 106 118 129 67 0
Totale 2.992